IRIS
MONDELLI, MARIO UMBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.148
AS - Asia 8.068
EU - Europa 6.513
SA - Sud America 1.216
AF - Africa 235
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 12
AN - Antartide 1
Totale 26.211
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.918
CN - Cina 3.958
SG - Singapore 1.782
IE - Irlanda 1.389
BR - Brasile 917
UA - Ucraina 887
HK - Hong Kong 871
DE - Germania 802
FI - Finlandia 731
VN - Vietnam 707
RU - Federazione Russa 642
IT - Italia 625
FR - Francia 453
SE - Svezia 381
GB - Regno Unito 328
IN - India 156
CA - Canada 132
AR - Argentina 104
BD - Bangladesh 92
ZA - Sudafrica 85
IQ - Iraq 69
JP - Giappone 63
MX - Messico 60
EC - Ecuador 54
ID - Indonesia 48
PL - Polonia 43
CO - Colombia 38
TR - Turchia 38
NL - Olanda 36
PK - Pakistan 35
VE - Venezuela 34
AT - Austria 32
ES - Italia 31
MA - Marocco 28
SA - Arabia Saudita 27
UZ - Uzbekistan 26
CZ - Repubblica Ceca 24
TN - Tunisia 20
CL - Cile 19
BE - Belgio 18
DZ - Algeria 18
KE - Kenya 18
EG - Egitto 17
PY - Paraguay 17
PH - Filippine 16
IR - Iran 15
KZ - Kazakistan 14
MY - Malesia 14
AU - Australia 13
JO - Giordania 13
AZ - Azerbaigian 12
NP - Nepal 12
PE - Perù 12
CH - Svizzera 11
IL - Israele 11
KG - Kirghizistan 11
UY - Uruguay 11
LT - Lituania 10
BH - Bahrain 9
OM - Oman 9
TH - Thailandia 9
BO - Bolivia 7
GA - Gabon 7
AE - Emirati Arabi Uniti 6
AL - Albania 6
BG - Bulgaria 6
EE - Estonia 6
EU - Europa 6
GR - Grecia 6
LB - Libano 6
NI - Nicaragua 6
SN - Senegal 6
CR - Costa Rica 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
HR - Croazia 5
KR - Corea 5
PS - Palestinian Territory 5
CI - Costa d'Avorio 4
HU - Ungheria 4
JM - Giamaica 4
KW - Kuwait 4
LV - Lettonia 4
MU - Mauritius 4
PR - Porto Rico 4
QA - Qatar 4
RO - Romania 4
SI - Slovenia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AM - Armenia 3
AO - Angola 3
BA - Bosnia-Erzegovina 3
CY - Cipro 3
DK - Danimarca 3
GT - Guatemala 3
LU - Lussemburgo 3
MD - Moldavia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
SV - El Salvador 3
Totale 26.149
Salva come PNG Salva come JPEG
Città #
Chandler 1.439
Dublin 1.385
Jacksonville 1.192
Ashburn 1.091
Singapore 906
Nanjing 904
Hong Kong 861
San Jose 840
Dallas 709
Beijing 521
Boardman 474
Nanchang 380
Princeton 322
Lawrence 289
Lauterbourg 284
Wilmington 271
Shenyang 254
Hebei 237
Changsha 231
Ho Chi Minh City 221
Jiaxing 220
Los Angeles 191
Helsinki 186
Tianjin 174
Milan 162
Medford 159
Hanoi 158
Munich 156
Hangzhou 139
New York 123
Buffalo 122
Redondo Beach 122
Moscow 120
Ann Arbor 99
Shanghai 93
São Paulo 81
Pavia 75
Toronto 73
Verona 69
Tokyo 61
Turku 60
Woodbridge 60
Johannesburg 59
Orem 59
Norwalk 57
Seattle 48
Da Nang 42
Santa Clara 40
The Dalles 37
Brooklyn 36
Warsaw 36
Frankfurt am Main 35
Chicago 34
Zhengzhou 33
Baghdad 31
Chennai 31
Nuremberg 31
Guangzhou 30
Jinan 30
Des Moines 29
Haiphong 29
Quito 27
Rio de Janeiro 27
Fairfield 26
Montreal 26
Denver 24
London 24
Falkenstein 23
Tashkent 23
Dong Ket 22
Boston 21
Phoenix 21
San Francisco 21
Brasília 20
Columbus 20
Falls Church 20
Houston 20
Manchester 20
Pune 20
Auburn Hills 19
Kunming 19
Curitiba 18
Stockholm 18
Amsterdam 17
Brussels 17
Dhaka 17
Lahore 17
Nairobi 17
Washington 17
Belo Horizonte 16
Council Bluffs 16
Guayaquil 15
Ningbo 15
Atlanta 14
Biên Hòa 14
Piscataway 14
Vienna 14
Berlin 13
Can Tho 13
Mexico City 13
Totale 16.979
Salva come PNG Salva come JPEG
Nome #
MICA/B-targeted antibody promotes NK cell-driven tumor immunity in patients with intrahepatic cholangiocarcinoma 315
Mapping the human genetic architecture of COVID-19 289
A first update on mapping the human genetic architecture of COVID-19 189
Mapping the human genetic architecture of COVID-19 186
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 146
Lack of SARS-CoV-2 RNA environmental contamination in a tertiary referral hospital for infectious diseases in Northern Italy 136
Association of toll-like receptor 7 variants with life-threatening COVID-19 disease in males: Findings from a nested case-control study 132
Baseline and Breakthrough Resistance Mutations in HCV Patients Failing DAAs 131
Low risk for SARS-CoV2 symptomatic infection and early complications in paediatric patients during the ongoing CoVID19 epidemics in Lombardy 131
Clinical characteristics of coronavirus disease (COVID-19) early findings from a teaching hospital in Pavia, North Italy, 21 to 28 February 2020 130
Cross-reactive antibodies to hypervariable region 1 (HVR1) of the hepatitis C virus E2/gp70 glycoprotein 127
Emergency Department and Out-of-Hospital Emergency System (112—AREU 118) integrated response to Coronavirus Disease 2019 in a Northern Italy centre 124
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 121
CYP enzyme polymorphisms and susceptibility to HCV-related chronic liver disease and liver cancer. 117
A longitudinal analysis of hepatitis C virus replication following liver transplantation 117
COVID vaccination and asthma exacerbation: might there be a link? 117
Codon 72 polymorphisms of P53 gene does not affect the risk of cirrhosis and hepatocarcinoma in HCV-infected patients 115
Antibody responses to the hepatitis C virus (HCV) E2 protein: relationship to viraemia and prevalence in anti-HCV seronegative subjects. 115
A survey of hepatitis C virus infection in haemodialysis patients over a 7-years follow-up. 115
Alfa-interferon enhances non-T cell cytotoxicity fo rautologous hepatocytes in acute and chronic HBV infection 114
A major conformational B cell epitope on the HCV NS3 region defined by a human monoclonal antibody 114
Immunophatogenesis of viral hepatitis 114
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 114
Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. 113
Employing a systematic approach to biobanking and analyzing clinical and genetic data for advancing COVID-19 research 113
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 112
Acute hepatitis C: diagnosis and management. 111
Accuracy of the ElastPQ Technique for the Assessment of Liver Fibrosis in Patients with Chronic Hepatitis C: a "Real Life" Single Center Study 111
A human monoclonal antibody specific for a conserved epitope within the HCV protein 110
Hepatitis B virus structure and biology. 110
Detection of HTLV-III specific IgG in the CSF from patient with AIDS and encephalitis. 109
Abnormal alanine aminotransferase activity reflects exposure to hepatitis C virus in haemodialysis patients. 108
Antibody-negative chronic hepatitis C virus infection in immunocompetent children 107
Does the immune response play a role in the pathogenesis of chronic liver disease? 107
GB virus C infection in patients treated for childhood acute lymphoblastic leukemia 107
Recombinant human antibodies specific for hepatitis C virus proteins 107
Adenoviral mediated expression of anti-HCV NS3 single-chain Fv (sFv) antibody reduces HCV RNA in infected hepatocytes 107
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 106
A phase II, single arm multicenter study of low-dose rituximab for refractory mixed cryoglobulinemia secondary to hepatitis C virus infection 105
High Frequencies of Functional Virus-Specific CD4+ T Cells in SARS-CoV-2 Subjects With Olfactory and Taste Disorders 105
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 104
NKG2D and its ligands: key to immunotherapy of liver cancer? 104
Altered natural killer cell cytokine profile in type 2 autoimmune hepatitis 104
Patients with chronic hepatitis C receiving treatment with direct acting antivirals: How is this population changing? 104
A human monoclonal antibody specific for the N-terminus of hepatitis C virus nucleocapsid protein 103
An anti-mica/b antibody and il-15 rescue altered nkg2d-dependent nk cell responses in hepatocellular carcinoma 103
Clinical significance of hepatitis C virus genotypes. 102
Comparative evaluation of two serologic typing methods of hepatitis C virus 102
Absence of antibodies to human immunodeficiency virus in long-term institutionalized psychiatric patients. 102
Rapid response to COVID-19 outbreak in Northern Italy: how to convert a classic infectious disease ward into a COVID-19 response centre 102
Dissociation between serum and liver hepatitis C virus RNA levels in patients coinfected with human immunodeficiency virus 101
Association between class II allelles and protection or susceptibility to chronic hepatitis C 100
HCV genotype 1b is a major risk factor for the development of hepatocellular carcinoma (HCC) in cirrhotic patients: a prospective study 100
Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation 99
Molecular epidemiology of hepatitis C virus infection in intravenous drug users. 99
Clonality and specificity of cryoglobulins associated with HCV: pathophysiological implications 99
Characterization of monoclonal antibodies (mAb) from mice immunized with HCV hypervariable region 1 (HVR1) mimotopes. 99
Comparative evaluation of two serological typing methods for hepatitis C virus 99
Analysis of hepatitis C virus hypervariable region 1 sequence in cryoglobulinaemic patients and associated control 99
A human antibody specific for the hepatitis C virus core protein: expression in a bacterial system and characterization. 98
Low prevalence of antibodies to the HCV envelope region in anti-HCV seronegative, HCV RNA positive patients 98
Monocytes inhibit hepatitis C virus-induced TRAIL expression on CD56brightNK cells 98
B lymphocyte activation in chronic HCV infection: implications for autoimmune and lymphoproliferative disorders 97
PD-L1 negatively regulates CD4+CD25+Foxp3+ tregs by limiting STAT-5 phosphrylation in patients chronically infected with HCV 97
Defective cytotoxic function of intrahepatic natural killer cells in chronic hepatitis C virus infection 96
Epidemiology of HCV genotypes and risk of cirrhosis in apulia: a population-based case-control study 96
Engagement of Siglec-7 receptor induces a pro-inflammatory response selectively in monocytes 96
HCV intergenotype 2k/1b recombinant detected in a DAA-treated patient in Italy 96
The obesity paradox: Analysis from the SMAtteo COvid-19 REgistry (SMACORE) cohort 96
Defective DNAM-1 Dependent Cytotoxicity in Hepatocellular Carcinoma-Infiltrating NK Cells 95
Impaired intratumoral natural killer cell function in head and neck carcinoma 95
Is the natural history of hepatitis C virus carriers with normal aminotransferase really bening? 95
Severe COVID-19 in hospitalized carriers of single CFTR pathogenic variants 95
Management of infections pre- and post-liver transplantation: report of an AISF consensus conference. 94
Significance of hepatic expression of hepatitis C viral antigens in chronic hepatitis C 94
The impact of viral genotype on the natural history of HCV-induced cirrhosis: a prospective study 94
EASL Clinical Practice Guidelines: management of hepatitis C virus infection 94
ANTIBODY RESPONSES TO HEPATITIS C VIRUS HYPERVARIABLE REGION 1: EVIDENCE FOR CROSS-REACTIVITY AND IMMUNE-MEDIATED SEQUENCE VARIATION. 94
A human monoclonal antibody against hepatitis B surface antigen with potent neutralizing activity 94
Polymorphisms of microsomal epoxyde hydrolase gene and severity of HCV-related liver disease. 93
Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: a meta-analysis. 93
Modelling liver fibrosis progression in chronic hepatitis C: a study of 563 patients with sequential liver biopsies 93
T-cell cytotoxicity and circulating T-cell subsets in chronic HBV infection 93
HLA class II alleles confer protection or susceptibility to chronic hepatitis C 92
Detection of genomic and minus strand C virus RNA in the liver of chronic hepatitis C patients by strand-specific semi-quantitative RT-PCR 92
Assessment of HCV RNA clearance under combination therapy for HCV genotype 1: performance of the transcription-mediated amplification (TMA) assay. 91
Characterization of cryoglobulins from patients with type II mixed cryoglobulinaemia associated with HCV 91
Lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection. 91
Optimization for the detection of hepatitis C virus (HCV) antigens in the liver 91
SIGNIFICANCE OF THE IMMUNE RESPONSE TO A MAJOR, CONFORMATIONAL B CELL EPITOPE ON THE HEPATITIS C VIRUS NS3 REGION DEFINED BY A HUMAN MONOCLONAL ANTIBODY 91
Direct-acting antivirals cure innate immunity in chronic hepatitis C 91
Genetic mechanisms of critical illness in COVID-19 91
Mutations at position 385 within the hypervariable region 1 (HVR1) of the hepatitis C virus (HCV) are rare and not rescricted to patients with cryoglobulinemia 90
Viral and host immune regulatory mechanisms in HCV infection 90
Relationship between expression of HBV antigenes in isolated hepatocytes and autologous lymphocyte cytotoxicity in patients with chronic HBV infection. 90
HCV viremia in hemodialysis patients 90
Antibody responses to hepatitis C virus hypervariable regione 1: evidence for cross-reactivity and immune-mediated sequence variation 89
Practice guidelines for the treatment of hepatitis C: Recommendations from an AISF/SIMIT/SIMAST expert opinion meeting 89
NK cell phenotype and function are profoundly different in patients with chronic HBV and HCV infections 88
Virological feaures of hepatitis C virus infection in hemodialysis patients 88
Totale 10.901
Salva come PNG Salva come JPEG
Categoria #
all - tutte 111.093
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 111.093
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021577 0 0 0 0 0 0 0 0 0 274 222 81
2021/20221.212 45 11 50 33 16 71 12 83 70 25 197 599
2022/20234.267 515 232 30 468 432 453 2 225 1.648 16 201 45
2023/20241.683 150 246 46 116 162 375 47 363 7 40 53 78
2024/20253.924 90 398 133 162 61 114 179 290 947 103 427 1.020
2025/20268.305 683 803 1.139 1.056 963 374 1.656 336 786 509 0 0
Totale 26.741